| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | 10% Owner | Chief Executive Officer
2 companies
Smith Patrick W is a 10% Owner at Insight Molecular Diagnostics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 89 sells.
Estimated insider holdings value: $1325.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 4,198 | $2.01 | $8,437.98 | +0.1% | +53.2% | +224.4% | |
| Jan 14, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 16,055 | $2.12 | $34,114.42 | +0.3% | +32.3% | +218.6% | |
| Dec 26, 2024 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 90,219 | $2.13 | $192,166.47 | +5.4% | +49.3% | +199.1% | |
| Oct 3, 2024 | Chief Executive Officer | Sell | 4,767 | $404.14 | $1,926,544.58 | - | +43.7% | +72.4% | ||
| Oct 2, 2024 | Chief Executive Officer | Sale+OE | 206,913 | $402.74 | $83,332,367.24 | -0.8% | +46.9% | +78.1% | ||
| Sep 4, 2024 | Chief Executive Officer | Sale+OE | 170,539 | $357.67 | $60,996,785.48 | -0.3% | +88.5% | +105.5% | ||
| Aug 27, 2024 | Chief Executive Officer | Sale+OE | 199,891 | $367.08 | $73,376,750.33 | -0.2% | +70.3% | +111.8% | ||
| Apr 3, 2023 | Chief Executive Officer | Sale+OE | 2,600 | $224.36 | $583,337.65 | - | -14.4% | +36.0% | ||
| Mar 31, 2023 | Chief Executive Officer | Sale+OE | 222,606 | $220.38 | $49,058,989.25 | -0.5% | -12.9% | +38.5% | ||
| Mar 28, 2023 | Chief Executive Officer | Sale+OE | 73,394 | $216.72 | $15,906,028.93 | -0.2% | -12.0% | +46.4% |